These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19724016)

  • 1. Treatment with SRT1720, a SIRT1 activator, ameliorates fatty liver with reduced expression of lipogenic enzymes in MSG mice.
    Yamazaki Y; Usui I; Kanatani Y; Matsuya Y; Tsuneyama K; Fujisaka S; Bukhari A; Suzuki H; Senda S; Imanishi S; Hirata K; Ishiki M; Hayashi R; Urakaze M; Nemoto H; Kobayashi M; Tobe K
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1179-86. PubMed ID: 19724016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel SIRT1 activator MHY2233 improves glucose tolerance and reduces hepatic lipid accumulation in db/db mice.
    Kim MJ; An HJ; Kim DH; Lee B; Lee HJ; Ullah S; Kim SJ; Jeong HO; Moon KM; Lee EK; Yang J; Akter J; Chun P; Moon HR; Chung HY
    Bioorg Med Chem Lett; 2018 Feb; 28(4):684-688. PubMed ID: 29402742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome.
    Sasaki Y; Shimada T; Iizuka S; Suzuki W; Makihara H; Teraoka R; Tsuneyama K; Hokao R; Aburada M
    Eur J Pharmacol; 2011 Jul; 662(1-3):1-8. PubMed ID: 21549692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice.
    Sheng X; Wang M; Lu M; Xi B; Sheng H; Zang YQ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E886-93. PubMed ID: 21364120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT1 upregulation protects against liver injury induced by a HFD through inhibiting CD36 and the NF‑κB pathway in mouse kupffer cells.
    Niu B; He K; Li P; Gong J; Zhu X; Ye S; Ou Z; Ren G
    Mol Med Rep; 2018 Aug; 18(2):1609-1615. PubMed ID: 29845302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dietary monosodium glutamate on trans fat-induced nonalcoholic fatty liver disease.
    Collison KS; Maqbool Z; Saleh SM; Inglis A; Makhoul NJ; Bakheet R; Al-Johi M; Al-Rabiah R; Zaidi MZ; Al-Mohanna FA
    J Lipid Res; 2009 Aug; 50(8):1521-37. PubMed ID: 19001666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Sirt1 activator, SRT1720, attenuates renal fibrosis by inhibiting CTGF and oxidative stress.
    Ren Y; Du C; Shi Y; Wei J; Wu H; Cui H
    Int J Mol Med; 2017 May; 39(5):1317-1324. PubMed ID: 28339034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRT1720 attenuates obesity and insulin resistance but not liver damage in the offspring due to maternal and postnatal high-fat diet consumption.
    Nguyen LT; Chen H; Mak C; Zaky A; Pollock C; Saad S
    Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E196-E203. PubMed ID: 29533740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat.
    Collison KS; Maqbool ZM; Inglis AL; Makhoul NJ; Saleh SM; Bakheet RH; Al-Johi MA; Al-Rabiah RK; Zaidi MZ; Al-Mohanna FA
    Obesity (Silver Spring); 2010 Jun; 18(6):1122-34. PubMed ID: 20111022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuin 1 Stimulation Attenuates Ischemic Liver Injury and Enhances Mitochondrial Recovery and Autophagy.
    Khader A; Yang WL; Godwin A; Prince JM; Nicastro JM; Coppa GF; Wang P
    Crit Care Med; 2016 Aug; 44(8):e651-63. PubMed ID: 26963320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRT1720, a SIRT1 activator, promotes tumor cell migration, and lung metastasis of breast cancer in mice.
    Suzuki K; Hayashi R; Ichikawa T; Imanishi S; Yamada T; Inomata M; Miwa T; Matsui S; Usui I; Urakaze M; Matsuya Y; Ogawa H; Sakurai H; Saiki I; Tobe K
    Oncol Rep; 2012 Jun; 27(6):1726-32. PubMed ID: 22470132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Honokiol activates the LKB1-AMPK signaling pathway and attenuates the lipid accumulation in hepatocytes.
    Seo MS; Kim JH; Kim HJ; Chang KC; Park SW
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):113-24. PubMed ID: 25737164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway.
    Hwang YP; Kim HG; Choi JH; Do MT; Chung YC; Jeong TC; Jeong HG
    J Nutr Biochem; 2013 Aug; 24(8):1469-78. PubMed ID: 23465592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1.
    Geng C; Xu H; Zhang Y; Gao Y; Li M; Liu X; Gao M; Wang X; Liu X; Fang F; Chang Y
    Sci China Life Sci; 2017 Nov; 60(11):1234-1241. PubMed ID: 28667519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIRT1 mediates the role of RNA-binding protein QKI 5 in the synthesis of triglycerides in non-alcoholic fatty liver disease mice via the PPARα/FoxO1 signaling pathway.
    Zhang W; Sun Y; Liu W; Dong J; Chen J
    Int J Mol Med; 2019 Mar; 43(3):1271-1280. PubMed ID: 30664220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SIRTUIN 1 ACTIVATOR SRT1720 PROTECTS AGAINST ORGAN INJURY INDUCED BY INTESTINAL ISCHEMIA-REPERFUSION.
    Hansen LW; Khader A; Yang WL; Prince JM; Nicastro JM; Coppa GF; Wang P
    Shock; 2016 Apr; 45(4):359-66. PubMed ID: 26263437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in the expression of hepatic genes involved in fatty acid metabolism in obese rats supplemented with taurine.
    Bonfleur ML; Borck PC; Ribeiro RA; Caetano LC; Soares GM; Carneiro EM; Balbo SL
    Life Sci; 2015 Aug; 135():15-21. PubMed ID: 26092479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigna nakashimae extract prevents hepatic steatosis in obese mice fed high-fat diets.
    Son Y; Jang MK; Jung MH
    J Med Food; 2014 Dec; 17(12):1322-31. PubMed ID: 25357150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fructose induces gluconeogenesis and lipogenesis through a SIRT1-dependent mechanism.
    Caton PW; Nayuni NK; Khan NQ; Wood EG; Corder R
    J Endocrinol; 2011 Mar; 208(3):273-83. PubMed ID: 21212096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.